ATC Group: J01DE01 Cefepime

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of J01DE01 in the ATC hierarchy

Level Code Title
1 J Antiinfectives for systemic use
2 J01 Antibacterials for systemic use
3 J01D Other beta-lactam antibacterials
4 J01DE Fourth-generation cephalosporins
5 J01DE01 Cefepime

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route Amount
PAREN - Parenteral 2 g

Active ingredients in J01DE01

Active Ingredient Description
Cefepime

Cefepime is a broad-spectrum, bactericidal antibiotic, with activity against a wide range of Gram-positive and Gram-negative bacteria, including many strains resistant to aminoglycosides or third generation cephalosporins. It has a reduced affinity for beta-lactamases.

Related product monographs

Title Information Source Document Type  
RENAPIME Powder for solution for injection / infusion Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
ROXIPIME Sterile powder for injection Health Sciences Authority (SG) MPI, Generic

Medicines in this ATC group

Brazil (BR)

Cyprus (CY)

Ecuador (EC)

Estonia (EE)

France (FR)

Japan (JP)

Lithuania (LT)

Mexico (MX)

Nigeria (NG)

Poland (PL)

Singapore (SG)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.